The global Wheelchair Market was valued at USD 8.9 billion in 2025 and is projected to grow from USD 10.0 billion in 2026 to USD 21.8 billion by 2033, registering a CAGR of 10.8% from 2026 to 2033. The market is experiencing robust growth, driven by the rising prevalence of mobility impairments, increasing geriatric population, growing incidence of chronic diseases, technological...

As 2026 begins, the global hepatology community is closely monitoring a wave of breakthrough data from Phase II and III trials that aim to permanently correct the ATP7B genetic mutation. Regulatory authorities in the European Union and the United States have recently signaled a willingness to accept biomarker-driven endpoints, such as long-term reduction in non-ceruloplasmin bound copper, to...

7 clinical breakthroughs reshaping acute intermittent porphyria care in 2026 The landscape for metabolic rare diseases has reached a critical inflection point in early 2026 as global health authorities fast-track next-generation RNA interference protocols. New clinical data emerging from European research hubs suggests that the management of hepatic porphyrin precursors is no longer a reactive...